









Markets
/
Stocks
/
nasdaq-avbp
/

Arrivent Biopharma Inc

AVBP

21.860USD

+0.510+2.39%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

893.03MMarket Cap

LossP/E TTM



Arrivent Biopharma Inc

21.860

+0.510+2.39%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Arrivent Biopharma Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2022Q4

FY2022Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-119.01%-35.80M

-36.87%-26.12M

-265.08%-68.01M

-8.31%-16.15M

-5.85%-16.34M

---19.09M

---18.63M

6.13%-14.91M

-55.57%-15.44M

---15.89M

---9.93M

Net income from continuing operations

-70.09%-34.98M

-43.54%-31.40M

-269.68%-64.39M

2.64%-20.63M

-42.80%-20.56M

---21.87M

---17.42M

-102.96%-21.19M

-22.37%-14.40M

---10.44M

---11.77M

Other non-cash items

----

---192.47M

----

Change in working capital

-235.28%-4.54M

-2.87%1.96M

-220.92%-5.89M

-40.80%3.53M

366.53%3.35M

--2.02M

---1.84M

207.25%5.96M

-172.76%-1.26M

---5.56M

--1.73M

-Change in prepaid expenses

-2277.85%-6.49M

-2032.93%-4.75M

-213.19%-1.59M

-64.66%1.43M

-86.35%298.00K

--246.00K

---508.00K

176.22%4.04M

167.29%2.18M

---5.30M

---3.24M

-Change in other current assets

----

100.00%0.00

97.14%-1.00K

-100.00%0.00

---18.00K

---1.00K

-3600.00%-35.00K

150.00%10.00K

--1.00K

--4.00K

Cash from non-recurring investing activities

Cash from operating activities

-119.01%-35.80M

-36.87%-26.12M

-265.08%-68.01M

-8.31%-16.15M

-5.85%-16.34M

---19.09M

---18.63M

6.13%-14.91M

-55.57%-15.44M

---15.89M

---9.93M

Investing cash flow

Net cash flow from investment products

---50.76M

--13.91M

--36.82M

-869.86%-192.47M

----

--25.00M

--0.00

----

--0.00

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

---50.76M

--13.91M

--36.82M

-869.86%-192.47M

----

--25.00M

--0.00

Financing cash flow

Cash flow from continuous financing activities

16183.43%86.47M

20592.56%75.11M

-96.36%6.76M

105.20%55.00K

151.40%531.00K

--363.00K

--185.63M

-100.96%-1.06M

---1.03M

--109.72M

--0.00

Net cash flow from common stock issuance/repurchase

--86.12M

23517.87%75.34M

-96.49%6.52M

--0.00

--319.00K

--185.63M

--0.00

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

--109.71M

--0.00

Proceeds from stock option exercised by employees

-90.77%49.00K

72.73%76.00K

29200.00%293.00K

-80.70%55.00K

1261.54%531.00K

--44.00K

--1.00K

1800.00%285.00K

--39.00K

--15.00K

--0.00

Net cash flow from other financing activities

--300.00K

---303.00K

---50.00K

100.00%0.00

----

---1.34M

---1.07M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

16183.43%86.47M

20592.56%75.11M

-96.36%6.76M

105.20%55.00K

151.40%531.00K

--363.00K

--185.63M

-100.96%-1.06M

---1.03M

--109.72M

--0.00

Net cash flow

Beginning cash balance

-62.24%112.77M

-84.29%49.87M

-50.60%74.29M

100.10%282.86M

89.23%298.67M

--317.39M

--150.39M

103.28%141.36M

98.62%157.83M

--69.54M

--79.46M

Current period cash flow changes

99.41%-93.00K

435.93%62.90M

-114.63%-24.43M

-2409.66%-208.56M

4.01%-15.81M

---18.72M

--167.00M

-90.38%9.03M

-65.98%-16.48M

--93.83M

---9.93M

Ending cash balance

-60.17%112.67M

-62.24%112.77M

-84.29%49.87M

-50.60%74.29M

100.10%282.86M

--298.67M

--317.39M

-7.95%150.39M

103.28%141.36M

--163.37M

--69.54M

Free cash flow

---35.80M

---26.12M

---68.01M

-8.31%-16.15M

----

---14.91M

-55.57%-15.44M

----

---9.93M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

